Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push – Reuters
Licensed article · Internal edition with publisher attribution
Live archive
Browse the live newspaper index by source, place, topic or keyword.
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution
Licensed article · Internal edition with publisher attribution